Legend Holdings Recorded a Revenue of RMB233.4 Billion in H1 2024

Legend Holdings Recorded a Revenue of RMB233.4 Billion in H1 2024

HONG KONG, Aug 30, 2024 – (ACN Newswire via SeaPRwire.com) – Legend Holdings Corporation (“Legend Holdings” or the “Company”, Stock Code: 3396. HK) announces the unaudited condensed consolidated interim results of the Group for the six months ended 30 June 2024 (the “Reporting Period”). In the first half of 2024, adhering to high-quality development driven […]

Inkeverse Group Announces 2024 Interim Financial Results

HONG KONG, Aug 30, 2024 – (ACN Newswire via SeaPRwire.com) – Inkeverse Group Limited (“Inkeverse” or “the Group”, Stock Code: 3700.HK) announces its full-year results for the period ended June 30, 2024. During the reporting period, the Group’s total revenue was RMB 3533.2 million, up 13.0% compared to the same period in 2023. Revenue from […]

國美零售持續聚焦主業 積極創新轉型降本增效

香港, 2024年8月30日 – (亞太商訊 via SeaPRwire.com) — 國美零售控股有限公司(香港聯合交易所代號:493.HK,“國美零售”或“公司”,及其子公司,統稱“集團”),今天公布其截至2024年6月30日止六個月(“報告期”)未經審計之六個月業績。 聚焦主業鞏固邊界 多舉措積極化解…

映宇宙公佈2024年中期業績公告

香港, 2024年8月30日 – (亞太商訊 via SeaPRwire.com) — 映宇宙集團有限公司(「映宇宙」或「集團」,股份代號:3700.HK)公佈截至2024年6月30日全年業績。 報告期內,集團總收益為3533.2百萬港元,較2023年同期增長13.0%;其中,集團增值服務總收益為2601….

Tong Ren Tang Chinese Medicine Announces 2024 Interim Results

Tong Ren Tang Chinese Medicine Announces 2024 Interim Results

HONG KONG, Aug 30, 2024 – (ACN Newswire via SeaPRwire.com)  Beijing Tong Ren Tang Chinese Medicine Company Limited (“Tong Ren Tang Chinese Medicine” or the “Company”, Stock code: 3613.HK) is pleased to announce the unaudited results of the Company and its subsidiaries (collectively referred to as the “Group”) for the six months ended 30 June […]

Wuling Motors’ Net Profit Surges 72.3% in H1 2024

Wuling Motors’ Net Profit Surges 72.3% in H1 2024

HONG KONG, Aug 30, 2024 – (ACN Newswire via SeaPRwire.com) – Liuzhou, a key industrial hub in Southwest China, has long been a pioneer in China’s industrial history. From manufacturing Guangxi’s first automobile and aircraft before the founding of the People’s Republic of China to becoming the second-largest industrial city in South China during the […]

同仁堂國藥宣佈2024年中期業績

同仁堂國藥宣佈2024年中期業績

香港, 2024年8月30日 – (亞太商訊 via SeaPRwire.com) — 北京同仁堂國藥有限公司(「同仁堂國藥」或「公司」,股份代號:3613.HK)欣然公佈公司及其附屬公司(統稱為「集團」)截至2024年6月30日止六個月(「本期內」)之未經審計業績。 2024年上半年,面對港元匯率持續高企…

天津銀行召開2024年中期業績發佈會

天津銀行召開2024年中期業績發佈會

香港, 2024年8月30日 – (亞太商訊 via SeaPRwire.com) — 8月29日,天津銀行召開2024年中期業績發布會。2024年上半年,天津銀行紮實做好金融「五篇大文章」,賦能「新質生產力」,積極踐行「四個善作善成」重要要求,聚焦「科技創新、產業煥新、城市更新」「盤活存量、培育增量、提升…

匯聚科技有限公司公佈截至二零二四年六月三十日止中期業績

香港, 2024年8月30日 – (亞太商訊 via SeaPRwire.com) — 匯聚科技有限公司(「匯聚科技」,股份代號:1729,連同其子公司合稱「集團」)欣然宣布集團截至二零二四年六月三十日止六個月(「本中期期間」)的中期財務業績。 於本中期期間,由於借貸成本居高不下及財政支持撤銷等因素,及地緣…

TIME Interconnect Technology Limited Announces Interim Results For the Six Months Ended 30 June 2024

HONG KONG, Aug 30, 2024 – (ACN Newswire via SeaPRwire.com) TIME Interconnect Technology Limited (“TIME Interconnect”, Stock Code: 1729.HK, with its subsidiaries collectively referred to as the “Group”) is pleased to announce its interim results for the six months ended 30 June 2024 (the “Current Interim Period”). During the Current Interim Period, the pace of economic […]

Fosun Pursues Solid Business Development with Predictable Profit

Fosun Pursues Solid Business Development with Predictable Profit

HONG KONG, Aug 30, 2024 – (ACN Newswire via SeaPRwire.com) – On 28 August 2024, Fosun International (HKEX: 0656) announced its 2024 interim results. During the reporting period, its revenue continued to grow, reaching RMB97.84 billion. Industrial operation profit maintained growth, reaching RMB3.47 billion, and profit attributable to owners of the parent was RMB720 million. […]

渤海銀行公佈2024年中期業績

渤海銀行公佈2024年中期業績

香港, 2024年8月30日 – (亞太商訊 via SeaPRwire.com) — 渤海銀行股份有限公司(「渤海銀行」或「公司」;股份代號:9668.HK)宣佈公司及其附屬公司(「集團」)截至2024年6月30日止六個月(「報告期」)之未經審計綜合中期業績。 2024年上半年,國際環境更趨複雜嚴峻,主要…

Hua Medicine Announces 2024 Interim Results

Hua Medicine Announces 2024 Interim Results

– Dorzagliatin (trade name: HuaTangNing, world’s first dual-acting glucokinase activator (GKA), successfully entered China’s National Reimbursement Drug List for Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance (the “NRDL”) at the end of 2023. Hua Medicine worked with sales promotion partner Bayer Healthcare Company Limited (“Bayer”) and 80 Tier 1 distributors to begin the […]